Lauren Merendino
2021
In 2021, Lauren Merendino earned a total compensation of $3.5M as Chief Commercial Officer at Myovant Sciences Ltd..
Compensation breakdown
| Non-Equity Incentive Plan | $175,000 |
|---|---|
| Option Awards | $1,425,545 |
| Salary | $461,721 |
| Stock Awards | $1,399,986 |
| Other | $1,425 |
| Total | $3,463,677 |
Merendino received $1.4M in option awards, accounting for 41% of the total pay in 2021.
Merendino also received $175K in non-equity incentive plan, $461.7K in salary, $1.4M in stock awards and $1.4K in other compensation.
Rankings
In 2021, Lauren Merendino's compensation ranked 3,865th out of 12,412 executives tracked by ExecPay. In other words, Merendino earned more than 68.9% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,865 out of 12,412 | 69th |
Division Manufacturing | 1,582 out of 5,498 | 71st |
Major group Chemicals And Allied Products | 646 out of 2,374 | 73rd |
Industry group Drugs | 574 out of 2,095 | 73rd |
Industry Pharmaceutical Preparations | 401 out of 1,542 | 74th |
Source: SEC filing on July 27, 2022.
Merendino's colleagues
We found three more compensation records of executives who worked with Lauren Merendino at Myovant Sciences Ltd. in 2021.